Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Rectal Neoplasms × zimberelimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Triple Negative Breast Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thymoma 1 Solid Tumor 1 Rectal Neoplasms 1 Oligometastatic Prostate Cancer 1 Neoplasms 1 Metastatic Urothelial Cancer 1 Melanoma 1 Lung Neoplasms 1 Lung Diseases 1 Locally Advanced Cervical Cancer 1 Kidney Neoplasms 1 Gestational Trophoblastic Disease 1 Gastro-enteropancreatic neuroendocrine tumor 1 Erythrocytosis, Familial, 4 1 Cholangiocarcinoma 1 Carcinoma, Renal Cell 1 Carcinoid Tumor 1 Breast Neoplasms 1 Bile Duct Neoplasms 1 Advanced Solid Tumors 1 Advanced Solid Tumor 1

Interventions

Capecitabine 24 Oxaliplatin 22 Radiotherapy 15 Fluorouracil 13 Surgical Procedures, Operative 11 Drug Therapy 8 Chemoradiotherapy 8 Bevacizumab 8 Leucovorin 7 Consolidation Chemotherapy 7 Radiation 6 XELOX 5 Specimen Handling 5 Irinotecan 5 Folfox protocol 5 spartalizumab 4 sintilimab 4 Neoadjuvant Therapy 4 trifluridine tipiracil drug combination 3 pembrolizumab 3 irinotecan sucrosofate 3 fludarabine 3 dehydroftorafur 3 Radiotherapy, Intensity-Modulated 3 Nivolumab 3 Mastectomy, Segmental 3 Magnetic Resonance Spectroscopy 3 Endoscopy 3 Cyclophosphamide 3 Cetuximab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05024097 2025-08-27

PANTHER

Weill Medical College of Cornell University

Phase 2 Recruiting

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡